Home / Europe / Portugal / Life Sciences & Healthcare

Life Sciences & Healthcare

In a ever-changing world, with new regulatory requirements, in which technology plays an increasingly important role in the development of global strategies, the area of health, medical devices, pharmaceuticals and new branches of sciences such as biotechnology raise several legal issues and present high complexity and specificity.

The transition to a remote and essentially digital working environment has not been particularly difficult, however, the diversity of entities involved, the existing regulation and the operation of the market itself raise several legal issues and present high complexity and specificity.

Whatever your opportunities or challenges may be, our dedicated team understands your needs and works to strategically define tailor-made solutions.

We can help you shape your strategy, manage risks and make the most of business opportunities in these areas:

  • Regulation
  • Licensing
  • Financing, mergers and acquisitions
  • Business restructuring
  • Litigation
  • Clinical Research
  • Distribution
  • Patents Protection and enforcement
  • Labelling
  • Safety and Health
  • Competition
  • Public Offers
  • Environment

We have an in-depth knowledge of how life sciences and healthcare law applies in practice across different markets and with cross-disciplinary teams, we work to provide advice close to our clients’ needs.


Feed

30/01/2024
What’s in a name? Updated EMA guideline on naming medicinal products processed...
The updated EMA Guideline on the acceptability of names for human medicinal products processed through the centralised procedure was adopted by CHMP in December 2023 and came into effect on 1 January...
08/01/2024
Adapting to the new EU Data Act: implications for medical devices and other...
In recent years, the European Commission developed a European data strategy, which aims to create a single European market in which data can circulate freely. As the European Commission has emphasized...
08/12/2023
COP28: Global Health Under the Spotlight
Health took centre stage at the first ever ‘Health Day’ at COP28 on 3 December. The program focused the attention of world leaders on the profound public health-related issues stemming from climate...
08/11/2023
CMS Life Sciences Vital Signs, Winter 2023
2023 has seen some significant legal developments impacting the life sciences industry, and as we look ahead to 2024, there are several important developments which we would like to keep our clients informed...
08/11/2023
Cannabis law and legislation in Portugal
Medical use Under the Portuguese Law, the use of cannabis for medical purposes is admissible, provided the necessary requirements and the mandatory licenses are obtained. The Portuguese legal framework...
28/09/2023
EP Case Law in Brief: Erroneous Disclosures
“Mistakes in a document do not in themselves constitute prior art such as to prevent the grant of a patent.”So begins section I.C. 4.9 of the Case Law of the Boards of Appeal. This statement, and...
15/08/2023
AI in healthcare inventions – technical or not technical?
SummaryRecent European Patent Office (EPO) Board of Appeal case T 1910/20 sits among a number of decisions regarding the discussion of what constitutes technical character in the field of healthcare...
28/06/2023
UK announces £21m AI roll-out across NHS
IntroductionOn 23 June 2023, the UK government announced a £21 million fund aimed at accelerating the deployment of Artificial Intelligence (“AI”) across the National Health Service (“NHS”)...
12/06/2023
CMS updates Global Expert Guide to Digital health apps and telemedicine
Digitisation is advancing steadily. Its pioneering innovations challenge all parties involved.One of the most important aspects in this area is the huge potential that lies in the digitisation of healthcare.In...
12/05/2023
Consultation on the EU’s interim emissions reduction target for 2040
Until 24 June 2023 the European Commission is consulting to gather views on the EU’s climate target for 2040.Since the Communication of the European Green Deal in late 2019, there have been a raft of...
10/05/2023
At last: invalidity and revocation actions now available before TM offices...
One of the most significant innovations introduced by the EU Trade Mark Directive 2015/2436 (the so-called trade mark reform package) was the requirement for all EU countries to implement – where not...
02/05/2023
CMS updates Expert Guide on cannabis law and legislation
CMS Expert Guide on cannabis law and le­gis­la­tion gives stakeholders detailed and updated information on the latest developments in cannabis regulation in key markets. The Guide now covers two new jur­is­dic­tions:...